Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    5059313 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated
Has Results
Effect of Ranitidine on Hyper-IgE Recurrent Infection (Job's) Syndrome
Conditions: JOB's Syndrome;   Hyper-IgE Recurrent Infection Syndrome;   Immune Deficiency
Interventions: Drug: Ranitidine;   Drug: Placebo
2 Recruiting Study of Clinical Features and Genetics of Hyperimmunoglobulin E Recurrent Infection
Condition: Job's Syndrome
Intervention:

Indicates status has not been verified in more than two years